Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects
- 31 May 2006
- journal article
- research article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 28 (5), 734-744
- https://doi.org/10.1016/j.clinthera.2006.05.004
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: A pooled analysis of data from randomized clinical trialsEpilepsy Research, 2005
- Clinical Pharmacokinetics of LevetiracetamClinical Pharmacokinetics, 2004
- Levetiracetam: Relative Bioavailability and Bioequivalence of a 10% Oral Solution (750 mg) and 750‐mg TabletsThe Journal of Clinical Pharmacology, 2003
- Pharmacokinetics and metabolism of 14 C-levetiracetam, a new antiepileptic agent, in healthy volunteersEuropean Journal of Clinical Pharmacology, 2003
- The KEEPER™ trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based studyEpilepsy Research, 2003
- Safety Profile of LevetiracetamEpilepsia, 2001
- Efficacy and Tolerability of Levetiracetam 3000 mg/d in Patients with Refractory Partial Seizures: A Multicenter, Double‐Blind, Responder‐Selected Study Evaluating MonotherapyEpilepsia, 2000
- Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial SeizuresEpilepsia, 2000
- Pharmacokinetic profile of levetiracetamPharmacology & Therapeutics, 2000
- Treating repetitive seizures with a rectal diazepam formulationNeurology, 1998